NeoGenomics Inc. 2024 SR
The report highlights NeoGenomics' commitment to oncology diagnostics and sustainability, focusing on stewardship, access, and ethics. Key achievements in 2024 include serving nearly 700,000 patients, eliminating foam inserts from test kits, and migrating the fleet to hybrid vehicles. The company launched a Volunteer Paid Time Off program and expanded leadership training. Environmental efforts resulted in LEED certification for its headquarters and a voluntary GHG inventory for Scope 1 and 2 emissions. Socially, the company improved employee engagement scores and maintained a diverse workforce, with women comprising 59.1% of the global staff.
Company: NeoGenomics Inc.
Sector: Healthcare & social services
Country: United States
Year: 2024
Type: SR
Pages: 31
Back to company
NeoGenomics Inc.
Corporate Social Responsibility Report
The report highlights NeoGenomics' commitment to oncology diagnostics and sustainability, focusing on stewardship, access, and ethics. Key achievements in 2024 include serving nearly 700,000 patients, eliminating foam inserts from test kits, and migrating the fleet to hybrid vehicles. The company launched a Volunteer Paid Time Off program and expanded leadership training. Environmental efforts resulted in LEED certification for its headquarters and a voluntary GHG inventory for Scope 1 and 2 emissions. Socially, the company improved employee engagement scores and maintained a diverse workforce, with women comprising 59.1% of the global staff.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Aug 1, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Renewable Energy
Water Consumption
Women on Board
Women in Management
Employees